Cargando…
Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI
BACKGROUND: Ejection time (ET), acceleration time (AT) and time between left ventricular and aortic systolic pressure peaks (T-LVAo) might be of diagnostic and prognostic use in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). AIM: We aimed to assess the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160203/ https://www.ncbi.nlm.nih.gov/pubmed/36656376 http://dx.doi.org/10.1007/s00392-023-02154-y |
_version_ | 1785037239072325632 |
---|---|
author | Grundmann, David Goßling, Alina Schmidt, Lennard Voigtlaender, Lisa Ludwig, Sebastian Linder, Matthias Waldschmidt, Lara Demal, Till Bhadra, Oliver D. Schaefer, Andreas Reichenspurner, Hermann Blankenberg, Stefan Conradi, Lenard Westermann, Dirk Seiffert, Moritz Schofer, Niklas |
author_facet | Grundmann, David Goßling, Alina Schmidt, Lennard Voigtlaender, Lisa Ludwig, Sebastian Linder, Matthias Waldschmidt, Lara Demal, Till Bhadra, Oliver D. Schaefer, Andreas Reichenspurner, Hermann Blankenberg, Stefan Conradi, Lenard Westermann, Dirk Seiffert, Moritz Schofer, Niklas |
author_sort | Grundmann, David |
collection | PubMed |
description | BACKGROUND: Ejection time (ET), acceleration time (AT) and time between left ventricular and aortic systolic pressure peaks (T-LVAo) might be of diagnostic and prognostic use in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). AIM: We aimed to assess the diagnostic value and prognostic impact of invasively measured ET, AT, and T-LVAo in patients undergoing TAVI. METHODS: A total of 1274 patients received invasive measurement of ET, AT and T-LVAo prior to TAVI. Anatomic AS severity was assessed by CT-derived aortic valve calcification density (AVC(d)). Impact on all-cause mortality was retrospectively analyzed. RESULTS: In multivariable linear regression, T-LVAo showed the strongest correlation with AVC(d). No prognostic impact of T-LVAo was found according to uni- and multivariable analyses. In contrast, using an individual C-statistic derived cutoff (C(D)), patients with ET or AT ≥ C(D) showed lower mortality rates compared to patients with ET or AT < C(D) (1-year mortality: ET ≥ vs. < C(D): 15.01vs. 33.1%, AT ≥ vs < C(D) 16.3 vs. 26.5%, p < 0.001). Moreover, multivariable analysis identified ET ≥ C(D) (HR 0.61 [95% CI 0.43–0.87; p < 0.007]) to be associated with beneficial outcome after TAVI, independent from clinical risk factors and echocardiography-derived parameters. CONCLUSION: Among the studied hemodynamic parameters T-LVAo provides the highest diagnostic value, whereas ET is an outcome predictor beyond clinical risk factors and echocardiographic parameters in AS patients following TAVI. These parameters could be of considerable use in diagnostic evaluation and risk assessment of patients scheduled for TAVI. GRAPHICAL ABSTRACT: [Image: see text] T-LVAo (yellow): defined as time between left ventricular and aortic systolic pressure peaks. ET (green): Ejection Time defined as time from the start to flow end. AT (orange): Acceleration time defined as time from the start to the peak flow. AOP: aortic pressure, AVC: aortic valve calcification, CI: confidence interval, HGAS: high-gradient aortic stenosis, LGAS: low-gradient aortic stenosis, LVP: left ventricular pressure, SD: standard deviation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-023-02154-y. |
format | Online Article Text |
id | pubmed-10160203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-101602032023-05-06 Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI Grundmann, David Goßling, Alina Schmidt, Lennard Voigtlaender, Lisa Ludwig, Sebastian Linder, Matthias Waldschmidt, Lara Demal, Till Bhadra, Oliver D. Schaefer, Andreas Reichenspurner, Hermann Blankenberg, Stefan Conradi, Lenard Westermann, Dirk Seiffert, Moritz Schofer, Niklas Clin Res Cardiol Original Paper BACKGROUND: Ejection time (ET), acceleration time (AT) and time between left ventricular and aortic systolic pressure peaks (T-LVAo) might be of diagnostic and prognostic use in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). AIM: We aimed to assess the diagnostic value and prognostic impact of invasively measured ET, AT, and T-LVAo in patients undergoing TAVI. METHODS: A total of 1274 patients received invasive measurement of ET, AT and T-LVAo prior to TAVI. Anatomic AS severity was assessed by CT-derived aortic valve calcification density (AVC(d)). Impact on all-cause mortality was retrospectively analyzed. RESULTS: In multivariable linear regression, T-LVAo showed the strongest correlation with AVC(d). No prognostic impact of T-LVAo was found according to uni- and multivariable analyses. In contrast, using an individual C-statistic derived cutoff (C(D)), patients with ET or AT ≥ C(D) showed lower mortality rates compared to patients with ET or AT < C(D) (1-year mortality: ET ≥ vs. < C(D): 15.01vs. 33.1%, AT ≥ vs < C(D) 16.3 vs. 26.5%, p < 0.001). Moreover, multivariable analysis identified ET ≥ C(D) (HR 0.61 [95% CI 0.43–0.87; p < 0.007]) to be associated with beneficial outcome after TAVI, independent from clinical risk factors and echocardiography-derived parameters. CONCLUSION: Among the studied hemodynamic parameters T-LVAo provides the highest diagnostic value, whereas ET is an outcome predictor beyond clinical risk factors and echocardiographic parameters in AS patients following TAVI. These parameters could be of considerable use in diagnostic evaluation and risk assessment of patients scheduled for TAVI. GRAPHICAL ABSTRACT: [Image: see text] T-LVAo (yellow): defined as time between left ventricular and aortic systolic pressure peaks. ET (green): Ejection Time defined as time from the start to flow end. AT (orange): Acceleration time defined as time from the start to the peak flow. AOP: aortic pressure, AVC: aortic valve calcification, CI: confidence interval, HGAS: high-gradient aortic stenosis, LGAS: low-gradient aortic stenosis, LVP: left ventricular pressure, SD: standard deviation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-023-02154-y. Springer Berlin Heidelberg 2023-01-19 2023 /pmc/articles/PMC10160203/ /pubmed/36656376 http://dx.doi.org/10.1007/s00392-023-02154-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Grundmann, David Goßling, Alina Schmidt, Lennard Voigtlaender, Lisa Ludwig, Sebastian Linder, Matthias Waldschmidt, Lara Demal, Till Bhadra, Oliver D. Schaefer, Andreas Reichenspurner, Hermann Blankenberg, Stefan Conradi, Lenard Westermann, Dirk Seiffert, Moritz Schofer, Niklas Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI |
title | Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI |
title_full | Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI |
title_fullStr | Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI |
title_full_unstemmed | Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI |
title_short | Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI |
title_sort | prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing tavi |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160203/ https://www.ncbi.nlm.nih.gov/pubmed/36656376 http://dx.doi.org/10.1007/s00392-023-02154-y |
work_keys_str_mv | AT grundmanndavid prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT goßlingalina prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT schmidtlennard prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT voigtlaenderlisa prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT ludwigsebastian prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT lindermatthias prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT waldschmidtlara prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT demaltill prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT bhadraoliverd prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT schaeferandreas prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT reichenspurnerhermann prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT blankenbergstefan prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT conradilenard prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT westermanndirk prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT seiffertmoritz prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi AT schoferniklas prognosticimpactanddiagnosticvalueofinvasivelyderivedhemodynamicmeasuresinpatientswithsevereaorticstenosisundergoingtavi |